Healsun Biopharm

China
Hengyang, Hunan, China

Company profile

Healsun Biopharm company profile

Healsun Biopharm is a high-tech antibody/recombinant protein CRO/CDMO company, offering end-to-end service by multiple platforms from early developability assessments, stable cell line construction, culture medium customization, process development (including ADC), to pilot production, IND application and clinical production.

Business identity

Contact email
[email protected]
Phone number
0571-26201624
Operating status
Active
Company type
For Profit
Employee range
251-500 employees
Founded
2015-01-01, Year

Headquarters

Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Late Stage Venture
Funding rounds
6
Total equity funding
$84.2M
Last funding
Series C / 2025-11-19
Last equity funding
Series C
Investors
16
Lead investors
5
Founders
1
Articles
1

Founders and investors

Founders

Yuliang Huang

Lead investors

China Medical System Holdings LimitedHaibang CapitalKangzhe Venture CapitalKington CapitalShanghai Biomedical Industrial Equity Investment Fund

Investors

Dongfang JiafuHaitong CapitalShanghai Biomedical Industrial Equity Investment FundSinowisdomYinxinggu Capital